Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $8.98 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.83.
Market Cap
8.98T
Revenue
4.59T
Profits
200.36B
PE Ratio
44.83
Profit Margin
4.37%
Dividend Yield
0.39%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.85% | 2,757,541 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 609.12B | 1.23% | 10,167,707 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 449.63B | 0.04% | 6,872,705 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.95B | 0.64% | 10,718,109 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 314.90B | -0.10% | 13,472,723 | 65.77B |
| 6 | NVS | Novartis AG | 283.75B | 0.67% | 2,592,817 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 262.79B | -0.23% | 1,981,328 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 223.46B | -2.25% | 9,542,554 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 197.88B | -1.97% | 1,476,063 | 45.20B |
| 10 | AMGN | Amgen Inc. | 197.69B | -1.42% | 2,861,315 | 37.22B |
| 11 | ABT | Abbott Laboratories | 175.37B | 1.87% | 19,913,777 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 166.72B | -1.48% | 6,903,235 | 29.74B |
| 13 | DHR | Danaher Corporation | 144.26B | -0.58% | 4,965,855 | 24.78B |
| 14 | PFE | Pfizer Inc. | 142.77B | -0.36% | 45,629,587 | 63.32B |
| 15 | CVS | CVS Health Corporation | 137.12B | 0.91% | 6,608,660 | 405.62B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.04B | 0.38% | 12,261,477 | 48.48B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 123.26B | -0.08% | 1,568,123 | 12.22B |
| 18 | SYK | Stryker Corporation | 122.63B | -3.42% | 2,459,764 | 25.27B |
| 19 | ISRG | Intuitive Surgical, Inc. | 122.33B | -14.15% | 11,563,751 | 11.03B |
| 20 | MDT | Medtronic plc | 106.50B | -0.43% | 9,207,622 | 36.36B |
| 21 | SNY | Sanofi | 106.22B | 1.02% | 3,682,003 | 54.60B |
| 22 | GSK | GSK plc | 102.68B | -1.91% | 10,759,790 | 43.29B |
| 23 | MCK | McKesson Corporation | 98.51B | 0.01% | 1,118,657 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 82.34B | -3.77% | 1,544,259 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 80.92B | 0.07% | 1,940,386 | 201.11B |
| 26 | CI | The Cigna Group | 74.45B | -0.84% | 3,033,933 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 68.85B | -0.33% | 648,400 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 65.44B | -1.32% | 15,522,226 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.91B | -0.03% | 2,495,881 | 328.68B |
| 30 | ARGX | argenx SE | 53.83B | 0.30% | 277,704 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 53.52B | -0.09% | 2,053,095 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 53.32B | 2.51% | 4,689,211 | 28.34B |
| 33 | MDLN | Medline Inc. | 52.27B | -3.21% | 4,017,616 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 49.36B | -2.40% | 5,225,094 | 6.30B |
| 35 | HUM | Humana Inc. | 48.02B | 3.50% | 2,048,056 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.76B | -1.50% | 535,570 | 4.45B |
| 37 | HLN | Haleon plc | 44.24B | -0.10% | 9,009,480 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 43.58B | -1.10% | 2,108,793 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.58B | 3.90% | 1,832,639 | - |
| 40 | NTRA | Natera, Inc. | 38.87B | 0.58% | 1,014,525 | 2.50B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 37.30B | -0.59% | 3,612,360 | 17.35B |
| 42 | A | Agilent Technologies, Inc. | 37.13B | -3.41% | 4,247,327 | 7.23B |
| 43 | WAT | Waters Corporation | 36.23B | -2.44% | 573,587 | 3.77B |
| 44 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.71B | -5.54% | 1,378,519 | 4.29B |
| 45 | ONC | BeOne Medicines AG | 34.69B | -1.70% | 428,134 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 34.42B | -2.01% | 1,262,429 | 16.63B |
| 47 | ALC | Alcon Inc. | 34.29B | -0.51% | 2,653,475 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 33.50B | -0.60% | 2,540,469 | 2.44B |
| 49 | CNC | Centene Corporation | 32.81B | 3.99% | 4,781,461 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 32.10B | -0.46% | 7,544,442 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 31.74B | -1.01% | 1,252,256 | 3.32B |
| 52 | BIIB | Biogen Inc. | 30.41B | -1.40% | 1,151,284 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 29.58B | -1.71% | 5,069,951 | 4.82B |
| 54 | RMD | ResMed Inc. | 28.70B | -1.86% | 1,284,199 | 5.54B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 28.69B | -4.00% | 7,594,001 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 28.24B | -1.89% | 1,251,213 | 4.39B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.47B | -1.88% | 131,366 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.77B | -1.25% | 691,550 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.31B | -1.16% | 671,413 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.82B | 1.71% | 3,834,610 | 8.26M |
| 61 | MRNA | Moderna, Inc. | 24.53B | -2.11% | 4,551,992 | 2.23B |
| 62 | INSM | Insmed Incorporated | 23.48B | 0.80% | 2,002,885 | 819.56M |
| 63 | INCY | Incyte Corporation | 23.42B | 0.51% | 2,232,513 | 5.36B |
| 64 | DGX | Quest Diagnostics Incorporated | 23.32B | 0.61% | 955,496 | 11.28B |
| 65 | LH | Labcorp Holdings Inc. | 23.24B | 0.50% | 631,872 | 14.14B |
| 66 | BNTX | BioNTech SE | 23.13B | -0.09% | 1,131,173 | 3.23B |
| 67 | UTHR | United Therapeutics Corporation | 22.74B | 1.25% | 422,243 | 3.17B |
| 68 | STE | STERIS plc | 21.23B | -1.49% | 622,613 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.67B | 0.56% | 1,997,111 | 1.08B |
| 70 | VTRS | Viatris Inc. | 20.14B | -0.23% | 9,520,920 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.63B | -2.81% | 2,632,370 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.56B | -0.90% | 2,629,331 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.18B | -0.39% | 929,824 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 16.79B | -2.15% | 1,240,307 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.21B | 0.46% | 668,250 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 15.95B | 1.34% | 1,442,647 | 579.96M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.55B | 2.21% | 503,559 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.36B | -0.04% | 231,155 | 2.68B |
| 79 | DVA | DaVita Inc. | 15.21B | 1.26% | 545,737 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.73B | 3.71% | 3,816,889 | 13.65B |
| 81 | SOLV | Solventum Corporation | 14.08B | -0.48% | 1,115,196 | 8.26B |
| 82 | EXEL | Exelixis, Inc. | 14.06B | 0.43% | 2,555,562 | 2.38B |
| 83 | COO | The Cooper Companies, Inc. | 13.99B | -1.90% | 1,666,973 | 4.23B |
| 84 | SNN | Smith & Nephew plc | 13.03B | -2.61% | 2,034,938 | 6.16B |
| 85 | ICLR | ICON Public Limited Company | 13.02B | - | 579,566 | 8.27B |
| 86 | ELAN | Elanco Animal Health Incorporated | 12.90B | -0.46% | 4,011,369 | 4.89B |
| 87 | FMS | Fresenius Medical Care AG | 12.84B | 0.08% | 552,379 | 22.32B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.76B | 1.46% | 528,310 | 1.13B |
| 89 | ALGN | Align Technology, Inc. | 12.66B | -0.92% | 828,661 | 4.10B |
| 90 | PEN | Penumbra, Inc. | 12.52B | -0.40% | 480,696 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.29B | - | 1,248,955 | 2.90B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 11.84B | -2.97% | 878,315 | 708.24M |
| 93 | ABVX | ABIVAX Société Anonyme | 11.76B | -0.81% | 1,408,312 | 5.67M |
| 94 | MOH | Molina Healthcare, Inc. | 11.74B | 0.24% | 1,139,376 | 43.10B |
| 95 | BAX | Baxter International Inc. | 11.68B | -3.17% | 6,546,823 | 11.32B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.52B | -0.68% | 1,605,700 | 3.24B |
| 97 | PODD | Insulet Corporation | 11.36B | -0.23% | 1,396,164 | 2.90B |
| 98 | TECH | Bio-Techne Corporation | 11.24B | 0.49% | 3,076,479 | 1.21B |
| 99 | EHC | Encompass Health Corporation | 11.13B | -0.25% | 1,188,291 | 6.07B |
| 100 | CYTK | Cytokinetics, Incorporated | 10.89B | -0.22% | 1,588,489 | 105.82M |
| 101 | CRL | Charles River Laboratories International, Inc. | 10.81B | -2.10% | 710,194 | 4.03B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.72B | 0.36% | 2,841,079 | - |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.58B | -0.79% | 1,247,593 | 3.58B |
| 104 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.47B | 4.09% | 3,775,226 | 622.01M |
| 105 | KRYS | Krystal Biotech, Inc. | 10.46B | 3.82% | 683,084 | 417.30M |
| 106 | GMED | Globus Medical, Inc. | 10.45B | -4.83% | 2,270,414 | 3.10B |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.04B | -0.06% | 1,875,282 | - |
| 108 | HSIC | Henry Schein, Inc. | 10.00B | -0.50% | 1,167,025 | 13.38B |
| 109 | ENSG | The Ensign Group, Inc. | 9.93B | -0.93% | 703,687 | 5.27B |
| 110 | CORT | Corcept Therapeutics Incorporated | 9.72B | 0.89% | 1,893,054 | 769.10M |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.52B | 1.56% | 720,688 | 51.48M |
| 112 | TEM | Tempus AI, Inc. | 9.42B | -2.09% | 3,892,485 | 1.36B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 9.23B | 0.35% | 1,482,552 | 1.51B |
| 114 | GKOS | Glaukos Corporation | 9.21B | 0.93% | 375,761 | 551.35M |
| 115 | UHS | Universal Health Services, Inc. | 9.15B | -1.55% | 524,643 | 17.76B |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 6.73% | 519,117 | 74.06M |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 8.99B | -0.48% | 2,572,809 | 1.06B |
| 118 | BRKR | Bruker Corporation | 8.86B | -1.72% | 2,325,642 | 3.46B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | -0.06% | 5,373,713 | 18.07M |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.81B | 6.49% | 1,091,487 | - |
| 121 | ALKS | Alkermes plc | 8.79B | 1.50% | 1,713,654 | 1.56B |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.77B | 2.01% | 282,211 | 7.46M |
| 123 | OSCR | Oscar Health, Inc. | 8.76B | 0.83% | 3,328,870 | 13.30B |
| 124 | QGEN | Qiagen N.V. | 8.51B | -0.87% | 2,217,680 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.46B | -1.59% | 530,825 | 3.87B |
| 126 | RGEN | Repligen Corporation | 8.31B | -0.88% | 912,390 | 763.34M |
| 127 | IMVT | Immunovant, Inc. | 8.27B | 3.34% | 882,225 | - |
| 128 | HQY | HealthEquity, Inc. | 8.17B | -1.03% | 778,422 | 1.34B |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 8.15B | 1.12% | 287,199 | 2.59B |
| 130 | PCVX | Vaxcyte, Inc. | 8.12B | 0.29% | 1,128,025 | - |
| 131 | IBRX | ImmunityBio, Inc. | 8.04B | 3.09% | 9,025,459 | 140.98M |
| 132 | TGTX | TG Therapeutics, Inc. | 7.78B | -0.11% | 3,408,548 | 700.35M |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.60B | -2.49% | 9,909,472 | 2.37B |
| 134 | AVTR | Avantor, Inc. | 7.56B | -1.69% | 10,852,155 | 6.55B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.31B | 0.48% | 773,302 | 217.17M |
| 136 | PACS | PACS Group, Inc. | 7.30B | 1.10% | 710,480 | 5.43B |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.25B | 1.28% | 435,891 | 569.61M |
| 138 | LQDA | Liquidia Corporation | 7.11B | 6.20% | 1,202,844 | 288.07M |
| 139 | LNTH | Lantheus Holdings, Inc. | 7.00B | 2.36% | 1,124,303 | 1.55B |
| 140 | CHE | Chemed Corporation | 6.74B | 1.70% | 180,220 | 2.54B |
| 141 | HNGE | Hinge Health, Inc. | 6.74B | 1.29% | 1,911,097 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.68B | 3.00% | 1,914,573 | - |
| 143 | ERAS | Erasca, Inc. | 6.65B | 0.79% | 6,704,607 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 6.60B | 1.91% | 1,342,611 | 7.50M |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.52B | 0.09% | 704,131 | 827.11M |
| 146 | CGON | CG Oncology, Inc. | 6.34B | 3.38% | 1,058,944 | 5.07M |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.33B | 2.18% | 811,946 | - |
| 148 | GRFS | Grifols, S.A. | 6.28B | -0.82% | 326,764 | 8.58B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.01B | 2.34% | 278,328 | 274.48M |
| 150 | BLLN | BillionToOne, Inc. | 5.99B | 1.66% | 618,073 | 354.54M |
| 151 | TFX | Teleflex Incorporated | 5.96B | -0.45% | 369,050 | 2.13B |
| 152 | BLTE | Belite Bio, Inc | 5.90B | -0.39% | 155,023 | - |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.88B | 0.43% | 1,487,083 | - |
| 154 | TWST | Twist Bioscience Corporation | 5.84B | 2.87% | 1,162,080 | 409.48M |
| 155 | BLCO | Bausch + Lomb Corporation | 5.80B | -3.27% | 333,984 | 5.21B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.77B | 10.75% | 1,025,195 | 1.34M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.69B | -1.05% | 2,118,219 | 3.05B |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.59B | 11.63% | 2,804,782 | - |
| 159 | TXG | 10x Genomics, Inc. | 5.55B | -1.66% | 2,567,097 | 638.78M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.27B | 2.59% | 1,475,503 | 536.20M |
| 161 | STVN | Stevanato Group S.p.A. | 5.23B | -4.63% | 268,829 | 1.39B |
| 162 | SHC | Sotera Health Company | 5.06B | -2.85% | 3,213,127 | 1.19B |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | -0.12% | 984,699 | 1.29B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.92B | 4.65% | 712,523 | 754.05M |
| 165 | RDNT | RadNet, Inc. | 4.89B | -1.27% | 820,878 | 2.14B |
| 166 | MMED | MiniMed Group, Inc. | 4.75B | 6.61% | 2,401,998 | 3.10B |
| 167 | VCYT | Veracyte, Inc. | 4.72B | -0.15% | 2,010,249 | 541.74M |
| 168 | CRSP | CRISPR Therapeutics AG | 4.71B | -1.63% | 1,620,300 | 4.10M |
| 169 | CAI | Caris Life Sciences, Inc. | 4.66B | 0.06% | 3,294,607 | 907.29M |
| 170 | MANE | Veradermics, Incorporated | 4.65B | 5.19% | 951,413 | - |
| 171 | LFST | LifeStance Health Group, Inc. | 4.49B | 2.57% | 4,267,252 | 1.49B |
| 172 | LIVN | LivaNova PLC | 4.43B | -1.33% | 445,739 | 1.43B |
| 173 | MMSI | Merit Medical Systems, Inc. | 4.41B | -2.06% | 770,301 | 1.54B |
| 174 | ACAD | ACADIA Pharmaceuticals Inc. | 4.38B | -0.12% | 1,207,376 | 1.10B |
| 175 | NVST | Envista Holdings Corporation | 4.35B | -0.93% | 1,786,347 | 2.81B |
| 176 | RLAY | Relay Therapeutics, Inc. | 4.34B | 2.79% | 2,157,335 | 10.68M |
| 177 | CELC | Celcuity Inc. | 4.31B | 0.10% | 1,310,305 | - |
| 178 | LEGN | Legend Biotech Corporation | 4.31B | -1.98% | 1,807,542 | 1.14B |
| 179 | VKTX | Viking Therapeutics, Inc. | 4.31B | 1.95% | 1,922,446 | - |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.28B | 4.11% | 744,699 | - |
| 181 | WAY | Waystar Holding Corp. | 4.27B | -3.88% | 2,202,483 | 1.16B |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.26B | 2.85% | 2,633,057 | 4.26B |
| 183 | TNGX | Tango Therapeutics, Inc. | 4.13B | 3.33% | 2,289,892 | 56.99M |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.04B | -0.09% | 765,263 | 2.23B |
| 185 | ICUI | ICU Medical, Inc. | 3.94B | -2.87% | 213,542 | 2.16B |
| 186 | DYN | Dyne Therapeutics, Inc. | 3.92B | 4.49% | 1,537,920 | - |
| 187 | DOCS | Doximity, Inc. | 3.87B | -3.11% | 2,253,748 | 644.86M |
| 188 | PBLS | Parabilis Medicines, Inc. | 3.76B | 1.69% | 472,532 | - |
| 189 | ELVN | Enliven Therapeutics, Inc. | 3.71B | 4.60% | 818,038 | - |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.70B | 2.03% | 704,411 | 22.57M |
| 191 | DNLI | Denali Therapeutics Inc. | 3.70B | 2.46% | 1,611,465 | - |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 3.67B | 3.71% | 3,233,068 | 295.41M |
| 193 | ALMS | Alumis Inc. | 3.65B | 5.25% | 1,001,235 | 8.40M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.64B | -3.88% | 681,247 | 787.85M |
| 195 | BKD | Brookdale Senior Living Inc. | 3.58B | -1.77% | 5,030,939 | 3.00B |
| 196 | TLX | Telix Pharmaceuticals Limited | 3.58B | -3.42% | 132,193 | 803.79M |
| 197 | NHC | National HealthCare Corporation | 3.56B | 1.57% | 131,368 | 1.53B |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.56B | 2.70% | 1,265,377 | 415.62M |
| 199 | OGN | Organon & Co. | 3.55B | 0.22% | 1,585,826 | 6.16B |
| 200 | HAE | Haemonetics Corporation | 3.54B | -0.82% | 493,007 | 1.33B |
| 201 | GPCR | Structure Therapeutics Inc. | 3.45B | 5.32% | 915,201 | - |
| 202 | RCUS | Arcus Biosciences, Inc. | 3.44B | 2.74% | 781,581 | 236.00M |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 0.22% | 938,876 | 225.27M |
| 204 | OPCH | Option Care Health, Inc. | 3.41B | -1.63% | 2,233,134 | 5.67B |
| 205 | PRVA | Privia Health Group, Inc. | 3.39B | -1.18% | 1,529,962 | 2.25B |
| 206 | WRBY | Warby Parker Inc. | 3.24B | -4.28% | 2,672,726 | 890.57M |
| 207 | ITGR | Integer Holdings Corporation | 3.24B | -4.22% | 476,597 | 1.86B |
| 208 | ACHC | Acadia Healthcare Company, Inc. | 3.17B | 2.65% | 2,755,151 | 3.37B |
| 209 | GRAL | GRAIL, Inc. | 3.12B | 0.92% | 413,767 | 156.12M |
| 210 | MBX | MBX Biosciences, Inc. | 2.99B | 7.89% | 898,470 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.91B | 3.65% | 243,190 | - |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | 2.87B | -3.11% | 1,500,530 | 670.00M |
| 213 | XRAY | DENTSPLY SIRONA Inc. | 2.81B | 1.44% | 6,070,087 | 3.68B |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.79B | -0.35% | 439,397 | 776.83M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -0.14% | 1,149,061 | 865.00K |
| 216 | QURE | uniQure N.V. | 2.77B | 2.26% | 958,200 | 18.09M |
| 217 | VERA | Vera Therapeutics, Inc. | 2.76B | -1.58% | 1,390,187 | - |
| 218 | BEAM | Beam Therapeutics Inc. | 2.74B | -3.03% | 1,912,917 | 164.01M |
| 219 | ESTA | Establishment Labs Holdings Inc. | 2.72B | 0.30% | 464,549 | 229.58M |
| 220 | TRVI | Trevi Therapeutics, Inc. | 2.71B | 9.85% | 8,312,192 | - |
| 221 | ATAI | AtaiBeckley Inc. | 2.67B | 0.98% | 41,848,899 | 3.49M |
| 222 | KOD | Kodiak Sciences Inc. | 2.66B | 3.37% | 491,666 | - |
| 223 | SLS | SELLAS Life Sciences Group, Inc. | 2.59B | 12.26% | 11,293,042 | - |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 3.74% | 971,198 | 535.08M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.57B | 0.37% | 316,456 | 1.46B |
| 226 | TMDX | TransMedics Group, Inc. | 2.56B | -2.66% | 550,284 | 635.89M |
| 227 | IMNM | Immunome, Inc. | 2.53B | 0.54% | 688,485 | 4.02M |
| 228 | PGNY | Progyny, Inc. | 2.50B | 0.22% | 962,349 | 1.29B |
| 229 | RGC | Regencell Bioscience Holdings Limited | 2.49B | 5.02% | 152,745 | - |
| 230 | PHVS | Pharvaris N.V. | 2.44B | 3.80% | 236,448 | - |
| 231 | CLOV | Clover Health Investments, Corp. | 2.43B | 5.00% | 5,434,913 | 2.21B |
| 232 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 1.26% | 342,892 | - |
| 233 | NRIX | Nurix Therapeutics, Inc. | 2.40B | 0.22% | 794,891 | 36.77M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.04% | 645,894 | - |
| 235 | VCEL | Vericel Corporation | 2.38B | -2.45% | 472,154 | 292.09M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.36B | -1.34% | 443,129 | 1.09B |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.36B | 2.03% | 3,272,762 | 885.72M |
| 238 | AGIO | Agios Pharmaceuticals, Inc. | 2.36B | 2.30% | 773,957 | 66.05M |
| 239 | BHVN | Biohaven Ltd. | 2.32B | 8.96% | 3,506,224 | - |
| 240 | LMAT | LeMaitre Vascular, Inc. | 2.32B | -1.36% | 264,245 | 256.28M |
| 241 | NKTR | Nektar Therapeutics | 2.31B | 1.80% | 538,398 | 55.63M |
| 242 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | 10.69% | 320,016 | - |
| 243 | ZLAB | Zai Lab Limited | 2.27B | -2.65% | 958,634 | 453.28M |
| 244 | PVLA | Palvella Therapeutics, Inc. | 2.26B | 6.41% | 258,338 | - |
| 245 | NEOG | Neogen Corporation | 2.24B | -0.58% | 1,838,913 | 870.56M |
| 246 | IOVA | Iovance Biotherapeutics, Inc. | 2.23B | 7.30% | 23,478,579 | 285.61M |
| 247 | SION | Sionna Therapeutics, Inc. | 2.23B | 9.10% | 1,139,315 | - |
| 248 | MESO | Mesoblast Limited | 2.20B | -3.02% | 399,248 | 65.38M |
| 249 | AGL | agilon health, inc. | 2.17B | 7.11% | 370,652 | 5.82B |
| 250 | HTFL | HeartFlow, Inc. | 2.15B | -4.20% | 929,532 | 191.42M |
| 251 | AXGN | Axogen, Inc. | 2.12B | 0.18% | 1,200,575 | 238.11M |
| 252 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | -2.12% | 1,672,013 | 2.52B |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.10B | -0.80% | 566,368 | 1.93B |
| 254 | ADUS | Addus HomeCare Corporation | 2.09B | 0.62% | 213,581 | 1.45B |
| 255 | OMCL | Omnicell, Inc. | 2.09B | -2.40% | 532,855 | 1.23B |
| 256 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 6.04% | 1,220,500 | 42.95M |
| 257 | SGRY | Surgery Partners, Inc. | 2.07B | -3.91% | 805,521 | 3.34B |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 0.13% | 788,998 | 298.30M |
| 259 | CDNA | CareDx, Inc. | 2.05B | -1.51% | 1,763,665 | 412.82M |
| 260 | RAPP | Rapport Therapeutics, Inc. | 2.04B | 6.20% | 470,125 | 20.00M |
| 261 | HCM | HUTCHMED (China) Limited | 2.02B | -6.63% | 49,332 | 548.51M |
| 262 | ASTH | Astrana Health, Inc. | 2.02B | -0.35% | 709,535 | 3.53B |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 2.02B | 0.40% | 1,061,475 | 217.17M |
| 264 | NUVB | Nuvation Bio Inc. | 2.02B | 2.84% | 3,605,430 | 143.05M |
| 265 | ADMA | ADMA Biologics, Inc. | 2.02B | -1.14% | 5,589,557 | 509.86M |
| 266 | VRDN | Viridian Therapeutics, Inc. | 1.99B | - | 2,124,402 | 70.92M |
| 267 | PLSE | Pulse Biosciences, Inc. | 1.98B | 4.75% | 328,281 | 751.00K |
| 268 | ABCL | AbCellera Biologics Inc. | 1.97B | 4.95% | 4,229,381 | 79.21M |
| 269 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.97B | 4.29% | 1,254,027 | -665.00K |
| 270 | GHRS | GH Research PLC | 1.97B | -1.44% | 637,507 | - |
| 271 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -2.18% | 1,880,853 | 52.04M |
| 272 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 1.39% | 480,807 | 1.20B |
| 273 | URGN | UroGen Pharma Ltd. | 1.96B | 0.57% | 1,265,323 | 140.49M |
| 274 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | 0.72% | 705,259 | 899.11M |
| 275 | DMRA | Damora Therapeutics, Inc. | 1.94B | 4.10% | 489,024 | - |
| 276 | NBTX | Nanobiotix S.A. | 1.91B | 0.69% | 218,729 | 38.27M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.91B | 1.65% | 621,567 | - |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.91B | 0.91% | 532,141 | 367.34M |
| 279 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | -0.17% | 2,849,252 | 7.47M |
| 280 | NEO | NeoGenomics, Inc. | 1.90B | -1.55% | 10,766,529 | 745.97M |
| 281 | KARD | Kardigan, Inc. | 1.89B | 0.52% | 413,364 | - |
| 282 | WGS | GeneDx Holdings Corp. | 1.88B | 2.90% | 521,815 | 442.68M |
| 283 | UFPT | UFP Technologies, Inc. | 1.87B | -5.72% | 179,951 | 608.85M |
| 284 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | 2.12% | 2,845,188 | 204.73M |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 4.57% | 769,461 | 10.00M |
| 286 | NVCR | NovoCure Limited | 1.84B | -3.05% | 856,320 | 674.41M |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.82B | 0.58% | 471,678 | - |
| 288 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -0.06% | 5,399,160 | 2.18B |
| 289 | STOK | Stoke Therapeutics, Inc. | 1.81B | -0.21% | 413,964 | 32.08M |
| 290 | BHC | Bausch Health Companies Inc. | 1.80B | -2.03% | 1,235,370 | 10.53B |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.80B | 4.01% | 245,634 | 87.16M |
| 292 | IMCR | Immunocore Holdings plc | 1.78B | 1.42% | 578,207 | 412.81M |
| 293 | ATRC | AtriCure, Inc. | 1.77B | -1.88% | 809,286 | 552.16M |
| 294 | PGEN | Precigen, Inc. | 1.76B | - | 2,967,831 | 31.60M |
| 295 | HROW | Harrow, Inc. | 1.74B | 3.94% | 827,722 | 268.68M |
| 296 | GENB | Generate Biomedicines, Inc. | 1.74B | -0.73% | 343,674 | 30.30M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.74B | 1.28% | 572,442 | 1.85B |
| 298 | BFLY | Butterfly Network, Inc. | 1.73B | -5.56% | 9,283,894 | 102.92M |
| 299 | ZYME | Zymeworks Inc. | 1.73B | - | 444,694 | 81.26M |
| 300 | ANAB | AnaptysBio, Inc. | 1.72B | 7.11% | 732,652 | 232.39M |
| 301 | MPLT | MapLight Therapeutics, Inc. | 1.72B | 1.75% | 778,797 | - |
| 302 | AAPG | Ascentage Pharma Group International | 1.71B | -8.14% | 12,127 | 82.08M |
| 303 | TDOC | Teladoc Health, Inc. | 1.70B | -0.42% | 3,613,650 | 2.51B |
| 304 | TRLV | Trulieve Cannabis Corp. | 1.69B | 4.52% | 582,838 | 1.17B |
| 305 | FTRE | Fortrea Holdings Inc. | 1.68B | -0.89% | 938,512 | 2.71B |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | -3.32% | 322,514 | 923.71M |
| 307 | CMPS | COMPASS Pathways plc | 1.67B | -0.64% | 7,160,839 | - |
| 308 | MLTX | MoonLake Immunotherapeutics | 1.63B | 3.52% | 726,276 | - |
| 309 | PSNL | Personalis, Inc. | 1.61B | -1.22% | 6,618,903 | 64.52M |
| 310 | INVA | Innoviva, Inc. | 1.60B | -2.25% | 541,150 | 420.69M |
| 311 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 1.27% | 1,610,318 | 314.85M |
| 312 | VIR | Vir Biotechnology, Inc. | 1.59B | 0.32% | 1,739,896 | 65.50M |
| 313 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -4.09% | 4,329,238 | 66.09M |
| 314 | RXRX | Recursion Pharmaceuticals, Inc. | 1.56B | -2.48% | 19,353,221 | 66.41M |
| 315 | INNV | InnovAge Holding Corp. | 1.56B | -3.12% | 322,027 | 949.17M |
| 316 | ENOV | Enovis Corporation | 1.56B | -3.56% | 987,237 | 2.28B |
| 317 | MAZE | Maze Therapeutics, Inc. | 1.56B | 3.50% | 335,931 | 20.00M |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.55B | 1.31% | 839,974 | - |
| 319 | SEPN | Septerna, Inc. | 1.51B | 5.83% | 306,430 | 72.26M |
| 320 | IART | Integra LifeSciences Holdings Corporation | 1.50B | -3.02% | 945,231 | 1.64B |
| 321 | PRGO | Perrigo Company plc | 1.48B | -3.94% | 2,668,501 | 4.18B |
| 322 | AHCO | AdaptHealth Corp. | 1.46B | 0.55% | 747,949 | 3.29B |
| 323 | PNTG | The Pennant Group, Inc. | 1.46B | 0.58% | 259,939 | 1.02B |
| 324 | INSP | Inspire Medical Systems, Inc. | 1.46B | -1.82% | 664,598 | 915.25M |
| 325 | ARDT | Ardent Health, Inc. | 1.46B | -0.49% | 390,717 | 6.43B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.43B | 1.83% | 339,758 | 95.13M |
| 327 | BLFS | BioLife Solutions, Inc. | 1.42B | -3.67% | 1,371,691 | 101.66M |
| 328 | OMDA | Omada Health, Inc. | 1.41B | 0.13% | 1,109,471 | 283.30M |
| 329 | ABSI | Absci Corporation | 1.41B | 0.79% | 3,719,042 | 1.84M |
| 330 | SVRA | Savara Inc. | 1.40B | - | 1,010,598 | - |
| 331 | AKTS | Aktis Oncology, Inc. | 1.38B | -0.52% | 260,632 | 8.28M |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.36B | 2.28% | 940,177 | 3.42B |
| 333 | PAHC | Phibro Animal Health Corporation | 1.35B | -3.51% | 241,104 | 1.50B |
| 334 | NVAX | Novavax, Inc. | 1.35B | -0.36% | 2,265,585 | 596.34M |
| 335 | STAA | STAAR Surgical Company | 1.32B | -8.76% | 1,908,848 | 290.38M |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.31B | -7.93% | 2,245,807 | 787.08M |
| 337 | IMTX | Immatics N.V. | 1.31B | 2.02% | 401,112 | 43.00M |
| 338 | CNMD | CONMED Corporation | 1.30B | -4.02% | 504,917 | 1.37B |
| 339 | XNCR | Xencor, Inc. | 1.30B | 16.86% | 1,684,195 | 97.36M |
| 340 | AHG | Akso Health Group | 1.29B | -3.21% | 4,334 | 14.84M |
| 341 | ARDX | Ardelyx, Inc. | 1.28B | 1.36% | 3,274,381 | 427.68M |
| 342 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -1.89% | 272,117 | 1.30M |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.27B | 0.84% | 696,109 | - |
| 344 | AVLN | Avalyn Pharma Inc. | 1.25B | 10.20% | 364,052 | - |
| 345 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 4.41% | 780,733 | - |
| 346 | MNKD | MannKind Corporation | 1.25B | -0.25% | 3,508,985 | 360.78M |
| 347 | IRMD | IRADIMED CORPORATION | 1.24B | -0.76% | 129,672 | 86.28M |
| 348 | JBIO | Jade Biosciences, Inc. | 1.24B | 1.86% | 659,521 | - |
| 349 | ALVO | Alvotech | 1.23B | 2.67% | 223,558 | 562.04M |
| 350 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 14.06% | 1,103,042 | - |
| 351 | AORT | Artivion, Inc. | 1.22B | -2.60% | 535,319 | 458.69M |
| 352 | AZTA | Azenta, Inc. | 1.21B | -1.83% | 407,883 | 596.48M |
| 353 | FBRX | Forte Biosciences, Inc. | 1.19B | 8.60% | 595,918 | - |
| 354 | QDEL | QuidelOrtho Corporation | 1.19B | -4.71% | 1,106,191 | 2.66B |
| 355 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | 4.85% | 2,100,446 | 1.03B |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | -0.52% | 316,577 | 796.33M |
| 357 | AVNS | Avanos Medical, Inc. | 1.17B | 0.04% | 748,614 | 715.90M |
| 358 | ETON | Eton Pharmaceuticals, Inc. | 1.16B | 13.79% | 1,279,033 | 86.93M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.15B | 0.89% | 461,080 | 79.76M |
| 360 | SDGR | Schrödinger, Inc. | 1.14B | -1.79% | 940,435 | 254.91M |
| 361 | CAPR | Capricor Therapeutics, Inc. | 1.13B | 1.67% | 1,165,293 | 11.13M |
| 362 | NUTX | Nutex Health Inc. | 1.12B | -0.86% | 122,901 | 879.95M |
| 363 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.65% | 2,120,299 | 71.80M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 1.12B | -0.85% | 126,097 | 787.69M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 6.81% | 72,311 | - |
| 366 | EYPT | EyePoint, Inc. | 1.12B | 1.99% | 1,283,890 | 7.61M |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | - | 1,667,483 | - |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | 0.10% | 2,120,042 | 322.02M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 7.80% | 594,761 | - |
| 370 | IVA | Inventiva S.A. | 1.08B | 2.21% | 862,365 | 7.94M |
| 371 | CERT | Certara, Inc. | 1.08B | -4.81% | 2,140,869 | 419.75M |
| 372 | ANRO | Alto Neuroscience, Inc. | 1.07B | 0.77% | 777,370 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | -0.54% | 247,201 | 1.03B |
| 374 | GDRX | GoodRx Holdings, Inc. | 1.06B | 0.64% | 1,515,621 | 787.89M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | 6.70% | 2,431,579 | 69.64M |
| 376 | CRON | Cronos Group Inc. | 1.05B | 1.45% | 745,850 | 159.54M |
| 377 | GMRS | GMR Solutions Inc. | 1.04B | -1.26% | 567,626 | 5.83B |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.02B | 8.33% | 1,244,919 | 59.00K |
| 379 | BIOA | BioAge Labs, Inc. | 1.01B | 2.93% | 458,709 | 10.32M |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.04% | 433,974 | 734.86M |
| 381 | BVS | Bioventus Inc. | 1.01B | -2.98% | 609,653 | 576.30M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 1.00B | 3.61% | 1,488,388 | - |
| 383 | JANX | Janux Therapeutics, Inc. | 991.61M | 2.65% | 805,838 | 13.73M |
| 384 | VOR | Vor Biopharma Inc. | 980.22M | 4.33% | 999,018 | - |
| 385 | KURA | Kura Oncology, Inc. | 964.09M | -0.28% | 814,981 | 71.64M |
| 386 | ANNX | Annexon, Inc. | 950.29M | -1.53% | 3,341,464 | - |
| 387 | SANA | Sana Biotechnology, Inc. | 944.68M | -0.63% | 2,691,060 | - |
| 388 | PHAR | Pharming Group N.V. | 926.15M | 1.35% | 6,978 | 369.49M |
| 389 | GERN | Geron Corporation | 923.79M | 1.41% | 4,784,001 | 196.12M |
| 390 | GLAS | Glass House Brands Inc. | 917.96M | 4.35% | 269,226 | 177.68M |
| 391 | ABUS | Arbutus Biopharma Corporation | 900.77M | -3.80% | 1,602,640 | 191.45M |
| 392 | LBRX | LB Pharmaceuticals Inc | 900.73M | 2.68% | 147,919 | - |
| 393 | OPK | OPKO Health, Inc. | 898.56M | - | 1,753,203 | 581.12M |
| 394 | INMD | InMode Ltd. | 889.23M | -0.83% | 609,926 | 374.64M |
| 395 | DBVT | DBV Technologies S.A. | 880.40M | -1.08% | 566,171 | 5.04M |
| 396 | TBPH | Theravance Biopharma, Inc. | 877.45M | -0.24% | 449,526 | 109.78M |
| 397 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,109,588 | 238.37M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 870.61M | -0.58% | 338,457 | 720.53M |
| 399 | PHAT | Phathom Pharmaceuticals, Inc. | 868.97M | -0.27% | 480,187 | 204.89M |
| 400 | REPL | Replimune Group, Inc. | 858.76M | 7.46% | 3,713,343 | - |
| 401 | SLDB | Solid Biosciences Inc. | 858.48M | -3.65% | 1,493,249 | - |
| 402 | ODTX | Odyssey Therapeutics, Inc. | 843.13M | 3.22% | 220,077 | 1.06M |
| 403 | HSTM | HealthStream, Inc. | 832.05M | -1.59% | 131,988 | 311.78M |
| 404 | AVR | Anteris Technologies Global Corp. | 823.49M | 1.32% | 1,148,846 | 1.85M |
| 405 | TENX | Tenax Therapeutics, Inc. | 809.80M | 5.11% | 808,315 | - |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 793.29M | 5.97% | 1,253,801 | 8.37M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 788.08M | -1.23% | 3,667,232 | 35.54M |
| 408 | DSGN | Design Therapeutics, Inc. | 785.08M | -0.32% | 468,168 | - |
| 409 | AURA | Aura Biosciences, Inc. | 770.99M | 1.45% | 408,707 | - |
| 410 | SIBN | SI-BONE, Inc. | 770.79M | -1.92% | 403,799 | 206.22M |
| 411 | BBNX | Beta Bionics, Inc. | 770.47M | 2.31% | 1,233,774 | 110.24M |
| 412 | DRUG | Bright Minds Biosciences Inc. | 755.06M | 2.55% | 157,446 | - |
| 413 | ZVRA | Zevra Therapeutics, Inc. | 754.90M | 0.08% | 655,698 | 122.29M |
| 414 | RIGL | Rigel Pharmaceuticals, Inc. | 750.07M | -2.71% | 196,505 | 299.77M |
| 415 | CADL | Candel Therapeutics, Inc. | 745.89M | 7.38% | 2,380,160 | - |
| 416 | MNPR | Monopar Therapeutics Inc. | 744.37M | 2.40% | 265,228 | - |
| 417 | NGNE | Neurogene Inc. | 743.47M | 2.22% | 473,445 | 925.00K |
| 418 | OCS | Oculis Holding AG | 736.13M | -3.33% | 304,143 | 1.40M |
| 419 | CSTL | Castle Biosciences, Inc. | 732.77M | -0.29% | 242,887 | 339.92M |
| 420 | IMMX | Immix Biopharma, Inc. | 729.70M | 1.89% | 1,058,309 | - |
| 421 | SSII | SS Innovations International, Inc. | 728.48M | 0.83% | 15,549 | 48.47M |
| 422 | CLYM | Climb Bio, Inc. | 727.21M | 0.95% | 1,374,330 | - |
| 423 | CBLL | CeriBell, Inc. | 710.29M | -2.19% | 314,275 | 95.07M |
| 424 | OMER | Omeros Corporation | 701.32M | 5.10% | 1,195,534 | 9.89M |
| 425 | EVO | Evotec SE | 699.69M | -0.51% | 28,657 | 859.03M |
| 426 | SPRY | ARS Pharmaceuticals, Inc. | 695.12M | -6.17% | 2,127,867 | 98.99M |
| 427 | SLBT | SL Science Holding Limited | 694.99M | -0.69% | 156,409 | - |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 685.72M | 3.01% | 269,659 | - |
| 429 | GYRE | Gyre Therapeutics, Inc. | 674.51M | -5.76% | 73,973 | 117.05M |
| 430 | FTH | Faeth Therapeutics, Inc. | 666.90M | -0.27% | 98,701 | - |
| 431 | PHR | Phreesia, Inc. | 662.01M | -1.65% | 613,478 | 495.59M |
| 432 | SGP | SpyGlass Pharma, Inc. | 660.98M | -4.77% | 107,379 | - |
| 433 | CRMD | CorMedix Inc. | 660.56M | 1.57% | 694,737 | 400.05M |
| 434 | EVH | Evolent Health, Inc. | 653.51M | 2.47% | 1,463,629 | 1.89B |
| 435 | TCMD | Tactile Systems Technology, Inc. | 648.27M | -2.28% | 173,525 | 343.52M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 643.67M | 5.20% | 1,480,369 | - |
| 437 | MDXG | MiMedx Group, Inc. | 640.47M | -2.93% | 1,194,200 | 389.42M |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 635.41M | -0.26% | 1,803,988 | 361.51M |
| 439 | CERS | Cerus Corporation | 627.15M | -2.49% | 2,428,480 | 216.56M |
| 440 | ALLO | Allogene Therapeutics, Inc. | 617.83M | - | 4,939,744 | 22.00K |
| 441 | TECX | Tectonic Therapeutic, Inc. | 615.14M | 6.36% | 289,263 | - |
| 442 | BWAY | BrainsWay Ltd. | 611.43M | 6.00% | 85,864 | 56.22M |
| 443 | NVCT | Nuvectis Pharma, Inc. | 603.40M | 2.90% | 331,001 | - |
| 444 | CTKB | Cytek Biosciences, Inc. | 596.64M | -0.43% | 680,764 | 204.17M |
| 445 | AGMB | AgomAb Therapeutics NV | 592.95M | -2.27% | 57,394 | - |
| 446 | MYGN | Myriad Genetics, Inc. | 583.69M | -0.16% | 734,441 | 829.00M |
| 447 | STTK | Shattuck Labs, Inc. | 577.40M | 6.51% | 2,968,973 | 1.00M |
| 448 | WEAV | Weave Communications, Inc. | 575.26M | -1.63% | 858,953 | 248.72M |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 574.52M | 1.38% | 598,912 | 88.24M |
| 450 | FLGT | Fulgent Genetics, Inc. | 572.56M | -1.90% | 161,447 | 320.35M |
| 451 | PRME | Prime Medicine, Inc. | 565.33M | -2.80% | 3,349,475 | 4.03M |
| 452 | ANGO | AngioDynamics, Inc. | 558.40M | -4.46% | 512,561 | 320.17M |
| 453 | ALT | Altimmune, Inc. | 558.14M | 0.70% | 2,963,769 | 36.00K |
| 454 | RLMD | Relmada Therapeutics, Inc. | 549.62M | -4.03% | 3,236,497 | - |
| 455 | NPCE | NeuroPace, Inc. | 548.23M | -2.37% | 89,136 | 99.53M |
| 456 | TOI | The Oncology Institute, Inc. | 534.91M | 1.71% | 1,484,196 | 545.76M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 532.01M | 1.57% | 145,331 | - |
| 458 | ASMB | Assembly Biosciences, Inc. | 531.30M | 3.75% | 312,835 | 71.10M |
| 459 | VSTM | Verastem, Inc. | 529.88M | 4.51% | 3,562,398 | 49.59M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 528.93M | -1.81% | 181,174 | - |
| 461 | CTEV | Claritev Corporation | 518.08M | -1.20% | 73,648 | 978.76M |
| 462 | ZURA | Zura Bio Limited | 517.74M | 3.81% | 758,448 | - |
| 463 | AQST | Aquestive Therapeutics, Inc. | 516.92M | 4.57% | 2,356,421 | 50.27M |
| 464 | ARVN | Arvinas, Inc. | 516.81M | -0.25% | 519,865 | 89.40M |
| 465 | DNA | Ginkgo Bioworks Holdings, Inc. | 516.72M | -4.58% | 1,158,383 | 151.40M |
| 466 | TLRY | Tilray Brands, Inc. | 512.92M | -1.15% | 2,396,861 | 858.28M |
| 467 | RGNX | REGENXBIO Inc. | 511.30M | -11.70% | 7,516,947 | 87.82M |
| 468 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 469 | SLN | Silence Therapeutics plc | 495.96M | -3.85% | 277,230 | 839.00K |
| 470 | KIDS | OrthoPediatrics Corp. | 493.54M | -5.72% | 128,150 | 243.30M |
| 471 | SOPH | SOPHiA GENETICS SA | 492.47M | 0.69% | 362,911 | 81.18M |
| 472 | NRC | NRC Health | 490.85M | -0.73% | 52,691 | 138.64M |
| 473 | CBIO | Crescent Biopharma, Inc. | 490.13M | -2.38% | 318,206 | 11.88M |
| 474 | PROK | ProKidney Corp. | 489.34M | 0.62% | 991,348 | 889.00K |
| 475 | SGMT | Sagimet Biosciences Inc. | 482.90M | 2.22% | 1,381,534 | - |
| 476 | RZLT | Rezolute, Inc. | 481.59M | 5.49% | 1,084,749 | - |
| 477 | ARTV | Artiva Biotherapeutics, Inc. | 474.22M | 7.96% | 360,176 | 251.00K |
| 478 | OFIX | Orthofix Medical Inc. | 468.08M | -2.61% | 329,355 | 825.37M |
| 479 | VALN | Valneva SE | 467.88M | -1.57% | 50,813 | 180.25M |
| 480 | VMD | Viemed Healthcare, Inc. | 465.79M | 0.50% | 212,636 | 286.57M |
| 481 | CABA | Cabaletta Bio, Inc. | 461.45M | 5.99% | 3,508,396 | - |
| 482 | ANL | Adlai Nortye Ltd. | 461.20M | 1.59% | 569,048 | 5.00M |
| 483 | OCGN | Ocugen, Inc. | 460.39M | -0.73% | 3,844,189 | 4.47M |
| 484 | EDIT | Editas Medicine, Inc. | 457.32M | 3.47% | 1,749,443 | 38.69M |
| 485 | OVID | Ovid Therapeutics Inc. | 455.40M | -0.41% | 1,065,364 | 7.12M |
| 486 | CLPT | ClearPoint Neuro, Inc. | 454.34M | 0.60% | 566,603 | 40.61M |
| 487 | PRTA | Prothena Corporation plc | 453.38M | 2.24% | 408,386 | 57.94M |
| 488 | KYTX | Kyverna Therapeutics, Inc. | 452.92M | 0.13% | 874,267 | - |
| 489 | HELP | Cybin Inc. | 449.38M | 2.98% | 3,109,300 | - |
| 490 | SI | Shoulder Innovations, Inc. | 447.74M | -4.17% | 80,543 | 53.89M |
| 491 | PACB | Pacific Biosciences of California, Inc. | 447.27M | -3.36% | 7,078,876 | 160.03M |
| 492 | CYH | Community Health Systems, Inc. | 447.00M | -2.37% | 1,231,879 | 12.29B |
| 493 | SRTA | Strata Critical Medical, Inc. | 445.61M | -1.53% | 729,388 | 228.58M |
| 494 | VREX | Varex Imaging Corporation | 444.65M | -1.95% | 375,371 | 857.50M |
| 495 | DCTH | Delcath Systems, Inc. | 442.22M | -0.31% | 369,326 | 90.44M |
| 496 | BNTC | Benitec Biopharma Inc. | 439.05M | 0.95% | 82,200 | - |
| 497 | EVMN | Evommune, Inc. | 437.26M | 3.67% | 769,861 | 10.00M |
| 498 | PBYI | Puma Biotechnology, Inc. | 434.17M | 1.55% | 256,264 | 227.18M |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.25M | 6.98% | 118,394 | - |
| 500 | PRLD | Prelude Therapeutics Incorporated | 416.55M | 0.48% | 180,698 | 16.72M |